Biosense Webster, Inc., part of Johnson & Johnson MedTech, today announced the European launch of the HELIOSTAR ™ Balloon Ablation Catheter – the first radiofrequency balloon ablation catheter – The ...
Symptomatic but benign thyroid nodules treated with a single session of ultrasound-guided thermal ablation show reductions in volume that are sustained over the course of 5 years, with radiofrequency ...
Medical Device Network on MSN
J&J agrees to acquire Atraverse Medical to advance cardiac ablation portfolio
Should the transaction complete, J&J will inherit Atraverse’s radiofrequency system for simplifying access to the heart’s ...
August 3, 2011 (Bad Krozingen, Germany) — Two recently published studies are raising concerns within the electrophysiology community about the risks of silent cerebral thromboembolic events in ...
Please provide your email address to receive an email when new articles are posted on . Radiofrequency ablation had a technical efficacy of 96.1% for adults with low-risk thyroid cancer. Tumor ...
A non-surgical procedure called radiofrequency ablation can be highly effective in reducing or eliminating chronic back and joint pain in patients. The procedure can provide long-term relief by ...
The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...
Medtronic has received FDA breakthrough device designation for its Sphere-9 catheter after early trial results showed 65.5% of patients remained free from ventricular tachycardia recurrence at six ...
MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices advisory panel voted against the Medtronic ...
Please provide your email address to receive an email when new articles are posted on . Cryoballoon ablation was noninferior to radiofrequency ablation in patients with atrial fibrillation and HFrEF.
Radiofrequency ablation (RFA) represents a rapidly advancing minimally invasive intervention for the management of chronic knee pain, particularly in patients with osteoarthritis and post-surgical ...
The cardiac ablation market growth is driven by the rising prevalence of cardiac arrhythmias, increasing awareness of minimally invasive treatment options, and technological advancements in ablation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results